A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects
This study has been completed.
Study NCT00602589
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: January 7, 2008
Last Updated: January 25, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
